Zepbound - Tirzepatide for obesity approval
Nov 10, 2023•23 min•Ep. 73
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Drs. Karl and Spencer discuss how tirzepatide is now approved for obesity.
Learn:
- When will it be available
- How much will is cost
- Any differences compared to Mounjaro
- Surmount 3 trial
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
For the best experience, listen in Metacast app for iOS or Android